| Code | CSB-RA013246MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody targets LY6G6D (Lymphocyte Antigen 6 Family Member G6D), a glycosylphosphatidylinositol-anchored cell surface protein belonging to the LY6/uPAR superfamily. LY6G6D is predominantly expressed in immune cells and has been implicated in immune regulation and cell signaling processes. This protein shows differential expression patterns in various immunological contexts and has garnered research interest for its potential roles in inflammatory responses and immune cell modulation. Aberrant expression of LY6G6D has been associated with autoimmune conditions and certain hematological disorders, making it a relevant target for immunological research.
Developed as a research-grade biosimilar to the reference antibody described in patent US20240190966A1, this antibody provides researchers with a reliable tool for investigating LY6G6D biology and function. It enables studies exploring the protein's role in immune cell behavior, signal transduction pathways, and disease mechanisms. This antibody serves as a valuable reagent for advancing understanding of LY6 family proteins in health and disease contexts.
There are currently no reviews for this product.